The EU has approved an artificial intelligence (AI) technology that can identify people at risk of a fatal heart attack, years before it strikes.
The CaRi-Heart technology, developed by British Heart Foundation (BFH) spinout company Caristo Diagnostics, utilises coronary CT angiogram (CTTA) scans already performed in clinical practice.
It uses AI and deep-learning technology to produce a fat attenuation index score (FAI-Score), which accurately measures inflammation of blood vessels in and around the heart.
A BHF-funded study involving around 4,000 patients found those with an abnormal FAI were up to nine times more likely to die of a heart attack in the next nine years than those with normal FAI readings.
It also found that around one third of patients initially considered low risk after a routine CCTA, had a much higher risk after CaRi-Heart was applied to their scan.
- Verizon Unveils New Virtual Care Platform
- New Revenue Cycle Management—And Its Challenges and Opportunities
- Telehealth: The Journey From Video Visits to Strategic Business Tool
- Lack of a Dedicated Revenue Cycle Management (RCM) Software = Loss of Revenue
- What to Look for in Application Programming Interfaces?